Literature DB >> 26547503

A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India-Outcome of screening.

Susairaj Priscilla1, Arun Nanditha1, Mary Simon1, Krishnamoorthy Satheesh1, Sathish Kumar1, Ananth Samith Shetty1, Chamukuttan Snehalatha1, Desmond G Johnston2, Ian F Godsland2, Nicholas J Wareham3, Ambady Ramachandran4.   

Abstract

AIMS: We describe a two-step screening approach using non-invasive risk assessment and glycated hemoglobin (HbA1c) to identify participants for a diabetes prevention trial.
METHODS: A total of 6030 non-diabetic persons of 35-55 years were screened using risk assessment for diabetes. Those with three or more risk factors were screened using point of care HbA1c test. For this study, participants in HbA1c categories of 6.0% (42.1 mmol/mol)-6.4% (46.4 mmol/mol) were selected and their characteristics were analyzed.
RESULTS: Among 6030 persons, 2835 (47%) had three or more risk factors for diabetes. Among those screened with HbA1c, 43.2% (1225) had HbA1c values of <6.0% (42.1 mmol/mol), 46.8% (1327) had HbA1c values between 6.0% (42.1 mmol/mol) and ≤ 6.4% (46.4 mmol/mol) and 10% (283) had undiagnosed diabetes with ≥6.5% (47.5 mmol/mol). Positive family history was present in 53.2%, 81.7% were obese and 14.8% were overweight.
CONCLUSIONS: Opportunistic screening using a two-step approach: diabetes risk profile and HbA1c measurement detected a large percentage of individuals with prediabetes. Prediabetic persons recruited to the trial had higher percentage of obesity and presence of positive family history than those who had lower HbA1c values. Outcomes from this trial will enable comparisons with the previous prevention studies that used blood glucose levels as the screening criteria.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  HbA1c; Primary prevention; Screening; Short messaging service

Mesh:

Substances:

Year:  2015        PMID: 26547503     DOI: 10.1016/j.diabres.2015.09.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.

Authors:  Qiuhong Gong; Ping Zhang; Jinping Wang; Jixiang Ma; Yali An; Yanyan Chen; Bo Zhang; Xinxing Feng; Hui Li; Xiaoping Chen; Yiling J Cheng; Edward W Gregg; Yinghua Hu; Peter H Bennett; Guangwei Li
Journal:  Lancet Diabetes Endocrinol       Date:  2019-04-26       Impact factor: 32.069

2.  Cut-off Value of Random Blood Glucose among Asian Indians for Preliminary Screening of Persons with Prediabetes and Undetected Type 2 Diabetes Defined by the Glycosylated Haemoglobin Criteria.

Authors:  Priscilla Susairaj; Chamukuttan Snehalatha; Arun Raghavan; Arun Nanditha; Ramachandran Vinitha; Krishnamoorthy Satheesh; Desmond G Johnston; Nicholas J Wareham; Ambady Ramachandran
Journal:  J Diabetes Clin Res       Date:  2019

Review 3.  Current Status and Future Directions of mHealth Interventions for Health System Strengthening in India: Systematic Review.

Authors:  Abhinav Bassi; Oommen John; Devarsetty Praveen; Pallab K Maulik; Rajmohan Panda; Vivekanand Jha
Journal:  JMIR Mhealth Uhealth       Date:  2018-10-26       Impact factor: 4.773

4.  Protocol for a clinical trial of text messaging in addition to standard care versus standard care alone in prevention of type 2 diabetes through lifestyle modification in India and the UK.

Authors:  Hazel Thomson; Nick Oliver; Ian F Godsland; Ara Darzi; Weerachai Srivanichakorn; Azeem Majeed; Desmond G Johnston; Arun Nanditha; Chamukuttan Snehalatha; Arun Raghavan; Priscilla Susairaj; Mary Simon; Krishnamoorthy Satheesh; Ambady Ramachandran; Stephen Sharp; Kate Westgate; Søren Brage; Nick Wareham
Journal:  BMC Endocr Disord       Date:  2018-09-10       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.